Skip to content

Effects of Dexmedetomidine on the Intraoperative Electroencephalogram During Endarterectomy Surgery

Effects of Dexmedetomidine on the Intraoperative Electroencephalogram During Endarterectomy Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00710437
Enrollment
22
Registered
2008-07-04
Start date
2005-04-30
Completion date
2009-11-30
Last updated
2017-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endarterectomy, Carotid

Keywords

Dexmedetomidine, Carotid Endarterectomy, Electroencephalogram

Brief summary

During elective carotid endarterectomy surgery, dexmedetomidine, an FDA approved medication, is now given as part of our standard anesthetic regimen based upon its reported ability to decrease anesthetic requirements and improve the peri-operative hemodynamic profile without compromising the EEG monitoring that is used during these procedures. Although this is consistent with our clinical impression, the effects of dexmedetomidine on the perioperative course and EEG monitoring have not been objectively evaluated at our institution.

Detailed description

Fifty sequential patient records will be identified from a search of the OR surgical schedules and reviewed: 25 patients before the introduction of dexmedetomidine and a standard anesthetic protocol and 25 patients after the introduction of the protocol. Data will be collected during an individual review of the pre-operative anesthetic evaluation, the intra-operative anesthetic record and the post-anesthesia care unit record and collated in an Excel spread sheet kept on a secure personal computer in the PI's office. All personal identifiers will be removed and the patients numbered sequentially before and after introduction of the clinical protocol. The data collected will be used to characterize the intraoperative anesthetic requirements, effects on EEG activity and the immediate postoperative recovery period. The review is expected to require 2 months to complete. This review will be restricted to records that already exist. No therapeutically removed tissues will be collected. There will be no additional tests. No blood samples will be collected. No additional procedures are involved in this study activity. There is no incomplete disclosure. The resources and personnel are currently available to complete this review. The entire project including data collection, analysis and summarization will be completed by the PI.

Interventions

DRUGDexmedetomidine

Steady state infusion 0.007 mcg/kg/min

Sponsors

University of California, Davis
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients undergoing elective carotid endarterectomy

Exclusion criteria

* Emergency surgery

Design outcomes

Primary

MeasureTime frameDescription
Effects of Dexmedetomidine on the Intraoperative Electroencephalogram During Endarterectomy SurgeryApril 2005 - November 2009Data collection and analysis complete. Permanently closed.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026